Vima LLC’s Gilead Sciences GILD Stock Holding History

Vima LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60	Closed	-$4.98K	–	174
2024 Q1	$4.98K	Hold	60	–	–	0.01%	294
2023 Q4	$4.86K	Buy	+60	New	+$4.67K	0.01%	304

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vima LLC's GILD Position: Q2 2024 in Review

Vima LLC sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 60 shares — an estimated $4.98K sold.

Vima LLC first reported a position in GILD in Q4 2023 and held it in 2 quarters. The position peaked at $4.98K in Q1 2024. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Vima LLC reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Vima LLC sold 60 Gilead Sciences shares in Q2 2024, an estimated $4.98K.
Vima LLC first reported a position in Gilead Sciences in Q4 2023 and held it in 2 quarters.
Vima LLC's Gilead Sciences position peaked at $4.98K in Q1 2024.
1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Vima LLC's 13F filing for Q2 2024, filed 8 Aug 2024.